Skip to main content Skip to navigation

Faculty and Staff Directory

George Diaz, MD, FIDSA

Clinical Professor
Department of Medical Education and Clinical Sciences

Education

  • Infectious Diseases Fellow, University of Washington
  • Chief Medical Resident, University of Utah
  • Internal Medicine Resident, University of Utah
  • MD, University of Oklahoma

Past Academic Positions

  • Professor (Hon), Norbert Weiner Postgraduate University, Lima, Peru

Clinical Positions

Teaching Assignments:

  • 601: Medicine Subspecialties-Infectious Diseases 4th year elective
  • Specialty Education Coordinator for Infectious Diseases, WSU Internal Medicine Residency

Clinical Appointments:

  • Division Chief of Medicine, Providence Regional Medical Center Everett
  • Medical Director for Antimicrobial Stewardship and Infection Prevention
  • System Provider Informaticist, Providence Health System

Honors and Awards

  • 2021: Seattle Met Top Doctors-Infectious Diseases
  • 2021: Fierce Health Care, Top 10 Most Influential Minority Executives in Healthcare
  • 2020: Puget Sound Business Journal Doctor of the Year
  • 2020: Mission Award, Providence Regional Medical Center Everett
  • 2011: President’s Award recipient, Providence Health and Services’ highest award for improvement in healthcare for Antimicrobial Stewardship implementation at Providence Regional Medical Center Everett
  • 2011: Qualis Health Awards of Excellence recipient, for improvement of patient safety and health at Providence Health and Services
  • 2011: Pharmacy Resource Council Award recipient for Antimicrobial Stewardship, Providence Health and Services
  • 2011: Preceptor Commendation University of Washington Medex NW PA Training Program.
  • 2000: Outstanding Intern of the Year, University of Utah, Department of Medicine,
  • 1999 Walter Mason Scholar, University of Oklahoma
  • 1999: Outstanding Hispanic Student of the year, University of Oklahoma Health Sciences Center
  • 1999: Medical Student Service Award, University of Oklahoma

Selected Publications

Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose. jamanetwork.com/journals/jama/fullarticle/2796847

Patient experience and healthcare utilization for a COVID-19 telemedicine home monitoring program offered in English and Spanish. journals.plos.org/plosone/article?id=10.1371/journal.pone.0270754

Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study. thelancet.com/journals/lanres/article/PIIS2213-2600(22)00042-X/fulltext

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. pubmed.ncbi.nlm.nih.gov/34609549/

Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity. academic.oup.com/cid/article/73/12/2193/6145124

Remdesivir and Mortality in Patients with COVID-19. academic.oup.com/cid/article/74/10/1812/6352176?login=false

Myocarditis and Pericarditis After Vaccination for COVID-19. jamanetwork.com/journals/jama/fullarticle/2782900

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. nejm.org/doi/full/10.1056/NEJMoa2015301

Compassionate Use of Remdesivir for Patients with Severe Covid-19. nejm.org/doi/full/10.1056/NEJMoa2007016

First Case of 2019 Novel Coronavirus in the United States. nejm.org/doi/full/10.1056/NEJMoa2001191

Additional Information

Dr. Diaz enjoys working with and mentoring medical students, residents, and faculty. In his free time, Dr. Diaz provides service to the Infectious Diseases Society of America as a spokesman, former member of the Clinical Affairs Committee and the fellow mentoring program. He also serves as a member of the Epic Infectious Diseases Steering Board, based in Wisconsin. His clinical research primarily focuses on COVID-19 therapeutics, vaccination outcomes, and long COVID with open protocols in these areas.

National Podcasts:

NEJM Catalyst, Innovations in Clinical Care March 27, 2020
Insights on the Role of Technology and Leadership in Covid-19 Care Delivery, from the Team that Treated America’s First Case
catalyst.nejm.org/doi/full/10.1056/CAT.20.0095

United States Department of State Foreign Press Briefing
Remdesivir as treatment for COVID-19 March 4 2020
2017-2021.state.gov/briefings-foreign-press-centers/remdesivir-as-treatment-for-covid-19/index.html

Infectious Diseases Society of America January 28th 2020
Treating the First Case of 2019-nCoV An Infectious Diseases doctor shares insights
bit.ly/2RY9lJz #2019nCoV

George Diaz
George Diaz, MD, FIDSA
Clinical Professor
george.diaz@wsu.edu